Status: current, Not sufficiently defined by necessary conditions definition status. Date: 19-Jul 2017. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
104594101000001113 | Atezolizumab 1.2g/20ml solution for infusion vials (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
104594201000001118 | Atezolizumab 1.2g/20ml solution for infusion vials | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Tecentriq 1200mg/20ml concentrate for solution for infusion vials (Originalis B.V.) | Is a | True | Atezolizumab 1.2g/20ml solution for infusion vials | Inferred relationship | Existential restriction modifier | |
Tecentriq 1200mg/20ml solution for infusion vials (Imported (United States)) | Is a | True | Atezolizumab 1.2g/20ml solution for infusion vials | Inferred relationship | Existential restriction modifier | |
Atezolizumab 1.2g/20ml solution for infusion vials 1 vial | Has VMP | True | Atezolizumab 1.2g/20ml solution for infusion vials | Inferred relationship | Existential restriction modifier | |
Tecentriq 1200mg/20ml concentrate for solution for infusion vials (Roche Products Ltd) | Is a | True | Atezolizumab 1.2g/20ml solution for infusion vials | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets